Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Petros Pharmaceuticals, Inc. (PTPI) had Return on Tangible Equity of -45.90% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-40.93M |
|
-- |
|
-- |
|
$1.80M |
|
$-1.80M |
|
$-0.24M |
|
$-2.04M |
|
$-2.04M |
|
$-2.04M |
|
$-2.04M |
|
$5.43M |
|
$-2.04M |
|
$-1.80M |
|
$-1.80M |
|
25.92M |
|
25.92M |
|
$-1.29 |
|
$-1.29 |
|
| Balance Sheet Financials | |
$7.40M |
|
-- |
|
-- |
|
$7.40M |
|
$2.95M |
|
-- |
|
-- |
|
$2.95M |
|
$4.45M |
|
$4.45M |
|
$4.45M |
|
42.28M |
|
| Cash Flow Statement Financials | |
$-4.67M |
|
-- |
|
$8.28M |
|
$3.71M |
|
$7.32M |
|
$3.61M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-45.90% |
|
|
Return on Tangible Equity |
-45.90% |
-27.60% |
|
-45.90% |
|
$0.11 |
|
$-0.18 |
|
$-0.18 |
|